Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preference after switch from Subutex to Suboxone in opioid-dependent adults
2006-006686-17Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Suboxone and buprenorphine in opioid use disorder (OUD) and heroin addiction, sponsored by Merck & Co. Primary endpoint: Overall satisfaction AUC. Started Feb 2007; status: completed.
02
Drugs
Suboxonebuprenorphine
03
Conditions
opioid use disorder (OUD)heroin addiction
Beyond the preview
Go deeper on 2006-006686-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006686-17.